ABSTRACT
The objective of this work was to analyze the legitimate use of personal data, through digital technologies, for proposing public health policies in the context of the COVID-19 pandemic. The method used in this research was deductive;as for the means, the research was bibliographic and for the ends, qualitative. The conclusion reached was that the collection of personal data and the circulation of information in the health sector are satisfactory for combating pandemics, such as SARS-COV-2, and with the current entry into force of the General Data Protection Law, legal certainty in the planning of public policies in this sector will be greater provided that the guiding principles for the treatment of data are observed, and a supervisory body is established other guidelines and a dialogue for the effective protection of personal data. © 2021 Revista Civilistica. All rights reserved.
Subject(s)
COVID-19 , Eye Diseases , Mucormycosis , Orbital Diseases , Humans , Mucormycosis/complications , Mucormycosis/diagnosis , Mucormycosis/drug therapy , SARS-CoV-2ABSTRACT
The persistence of pathogenic microorganisms in treated wastewater effluent makes disinfection crucial to achieve wastewater reuse. Membrane processes such as ultrafiltration and reverse osmosis (RO) have shown promising results for virus and other contaminant removal from treated wastewater effluents for reuse application. However, RO produces a concentrate stream which contains high concentrations of pathogens and contaminants that often requires treatment and volume reduction before disposal. Membrane distillation (MD) is a treatment process that can reduce RO concentrate volume while augmenting the potable water supply. MD is also a dual barrier approach for virus removal as it operates at a high temperature and permeates only the vapor phase through the membrane interface. The effects of temperature on viable virus concentration and membrane rejection of viruses in MD are investigated in this study using two nonenveloped phages frequently used as enteric virus surrogates (MS2 and PhiX174) and an enveloped pathogenic virus (HCoV-229E). At typical MD operating temperatures (greater than 65 °C), viable concentrations of all three viruses were reduced by thermal inactivation by more than 6-log10 for MS2 and PhiX174 and more than 3-log10 for HCoV-229E. Also, membrane rejection was greater than 6-log10 for MS2 and PhiX174 and greater than 2.5-log10 for HCoV-229E. © 2021 American Chemical Society.